A Multinational Randomised, Double-blind, Placebo Controlled Study to Evaluate the Antiviral Pharmacodynamic Effect, Safety, and Pharmacokinetics of Escalating Doses of BILB 1941 ZW Oral Solution Administered Q8H for Five Days to Patients With Chronic Hepatitis C Genotype 1 Virus Infection
Latest Information Update: 16 Oct 2014
Price :
$35 *
At a glance
- Drugs BILB 1941 (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 05 Nov 2010 New trial record.